Dashboard
Manage Tickers

QTRX Quanterix Corp

Nasdaq quanterix.com


$ 5.33 $ 0.10 (1.92 %)    

Thursday, 13-Nov-2025 15:59:58 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 5.32
$ 5.14
$ 5.03 x 150
$ 5.50 x 4
-- - --
$ 4.05 - $ 13.01
632,977
na
248.5M
$ 1.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-17-2025 12-31-2024 10-K
5 12-24-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-06-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-05-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-13-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-06-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 03-18-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-10-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-19-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

correction-quanterix-q3-adj-eps-035-beats-053-estimate-sales-40233m-beat-37845m-estimate
CORRECTION: Quanterix Q3 Adj. EPS $(0.35) ...
11/10/2025 23:36:39

Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.53) by ...

quanterix-affirms-fy2025-sales-guidance-of-130000m-135000m-vs-133465m-est
Quanterix Affirms FY2025 Sales Guidance of...
11/10/2025 21:02:42

Quanterix (NASDAQ:QTRX) affirms FY2025 sales outlook from $130.000 million-$135.000 million to $130.000 million-$135.000 millio...

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

earnings-preview-for-quanterix
Earnings Preview For Quanterix
11/07/2025 19:05:17

quanterix-from4-filing-shows-cfo-vandana-sriram-bought-4150-shares-at-an-average-price-of-479share
Quanterix From4 Filing Shows CFO Vandana S...
09/17/2025 14:26:58

- SEC Filing

quanterix-accelerator-laboratory-receives-new-york-state-clinical-laboratory-permit-permit-approval-enables-expanded-research-capabilities-and-underscores-commitment-to-accuracy-reliability-and-scientific-excellence
Quanterix Accelerator Laboratory Receives ...
08/21/2025 20:33:05

canaccord-genuity-downgrades-quanterix-to-hold-lowers-price-target-to-5
Canaccord Genuity Downgrades Quanterix to ...
08/11/2025 10:37:08

Canaccord Genuity analyst Kyle Mikson downgrades Quanterix (NASDAQ:QTRX) from Buy to Hold and lowers the price target from $...

update-quanterix-q2-adj-eps-047-misses-045-estimate-sales-24476m-miss-28170m-estimate
UPDATE: Quanterix Q2 Adj. EPS $(0.47) Miss...
08/07/2025 22:14:30

Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.45) b...

quanterix-raises-fy2025-sales-guidance-from-120000m-130000m-to-130000m-135000m-vs-123936m-est
Quanterix Raises FY2025 Sales Guidance fro...
08/07/2025 20:35:07

Quanterix (NASDAQ:QTRX) raises FY2025 sales outlook from $120.000 million-$130.000 million to $130.000 million-$135.000 million...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

earnings-preview-quanterix
Earnings Preview: Quanterix
08/06/2025 21:03:11

quanterix-enters-into-cooperation-agreement-with-kent-lake-capital-kent-lake-to-withdraw-director-nominations-and-shareholder-proposals-agreed-to-customary-standstill-and-voting-commitments
Quanterix Enters Into Cooperation Agreemen...
08/04/2025 13:32:10

quanterix-unveils-novel-p-tau-205-and-212-biomarker-assays-expanding-blood-based-alzheimers-detection-portfolio
Quanterix Unveils Novel p-Tau 205 And 212 ...
07/28/2025 11:20:41

Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa® technology included in more than 55...

on-july-14-quanterix-terminates-executives-of-akoya-biosciences-terminations-expected-to-save-28m-annually-expenses-of-33m-expected-for-severance-in-2025
On July 14, Quanterix Terminates Executive...
07/18/2025 20:45:14

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/14/2025 21:05:41

Core News & Articles
'NIH halts grant terminations 'effective i...
06/25/2025 19:03:03

https://www.statnews.com/2025/06/25/nih-halts-research-grant-terminations-email-shows/?utm_campaign=twitter_organic&utm_med...

quanterixs-ultra-sensitive-blood-test-platform-wins-medical-device-approval-in-south-korea
Quanterix's Ultra-Sensitive Blood Test Pla...
06/23/2025 11:34:41

Quanterix Corporation (NASDAQ:QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today a...

Core News & Articles
Kent Lake Raises Concerns Over Quanterix's...
05/23/2025 18:27:58

Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation...

Core News & Articles
Akoya Announced Receipt Of Unsolicited Pro...
05/21/2025 10:06:22

https://www.sec.gov/ix?doc=/Archives/edgar/data/1711933/000155837025008039/akya-20250520x8k.htm

canaccord-genuity-maintains-buy-on-quanterix-lowers-price-target-to-12
Canaccord Genuity Maintains Buy on Quanter...
05/13/2025 14:04:38

Canaccord Genuity analyst Kyle Mikson maintains Quanterix (NASDAQ:QTRX) with a Buy and lowers the price target from $15 to $12.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION